Support for psychedelic research continues to gain acceptance at the federal level as the National Institute on Drug Abuse (NIDA) announces a funding grant for research proposals of psychedelic medicine.
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) https://t.co/kr3xqmsJGM
— NIH Funding (@NIHFunding) May 16, 2023
Under the Department of Health and Human Services and the National Institutes of Health (NIH), three notices of funding opportunities were published this week, calling for submissions of research projects focused on how psychedelics could be used for substance use disorders (SUDs).
The government agencies are seeking proposals and research initiatives into the treatment of drug addiction using psychedelics, with an allocated $1.5 million in funding.
